Microfluidic Endothelium for Studying the Intravascular Adhesion of Metastatic Breast Cancer Cells
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The ability to properly model intravascular steps in metastasis is essential in identifying key physical, cellular, and molecular determinants that can be targeted therapeutically to prevent metastatic disease. Research on the vascular microenvironment has been hindered by challenges in studying this compartment in metastasis under conditions that reproduce in vivo physiology while allowing facile experimental manipulation. METHODOLOGY/PRINCIPAL FINDINGS: We present a microfluidic vasculature system to model interactions between circulating breast cancer cells with microvascular endothelium at potential sites of metastasis. The microfluidic vasculature produces spatially-restricted stimulation from the basal side of the endothelium that models both organ-specific localization and polarization of chemokines and many other signaling molecules under variable flow conditions. We used this microfluidic system to produce site-specific stimulation of microvascular endothelium with CXCL12, a chemokine strongly implicated in metastasis. CONCLUSIONS/SIGNIFICANCE: When added from the basal side, CXCL12 acts through receptor CXCR4 on endothelium to promote adhesion of circulating breast cancer cells, independent of CXCL12 receptors CXCR4 or CXCR7 on tumor cells. These studies suggest that targeting CXCL12-CXCR4 signaling in endothelium may limit metastases in breast and other cancers and highlight the unique capabilities of our microfluidic device to advance studies of the intravascular microenvironment in metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microfluidic assays have been designed to replicate certain aspects of several of these steps, such as EMT[13, 14], cancer cell invasion and adhesion[15–17], and intra-[18, 19] and extravasation[17, 20– 22] (see Text Box 3).”
From Microfluidics: A New Tool for Modeling Cancer–Immune Interactions (2016) · cites this paper as [15]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340 · cited 4×
“High levels of CXCL12 are expressed by parenchymal cells in organs commonly affected by metastatic breast cancer, such as liver, bone, and brain [21], suggesting that gradients of CXCL12 regulate homing of disseminated breast cancer cells to endothelium in these sites.”
BackgroundInfluentialChemokines and leukocyte traffic
Baggiolini, M. (1998) · Nature · doi:10.1038/33340 · Cited by 2,709 · cited 1×
“Trafficking of cells through the vasculature and arrest of circulating cells on endothelium at specific sites are critical steps in a wide variety of physiologic and disease processes, including immune surveillance”
BackgroundThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Breast cancer metastasis: markers and models
Weigelt, B., Peterse, J. L., & van't Veer, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1670 · Cited by 2,232 · cited 2×
“These cells are isolated from skin, a tissue with low metastatic potential for breast cancer [10], and facilitate low amounts of adhesion of cancer cells under non-stimulated conditions [44].”
Tumor metastasis: mechanistic insights and clinical challenges
Steeg, P. S. (2006) · Nature Medicine · doi:10.1038/nm1469 · Cited by 2,134
Traffic Signals on Endothelium for Lymphocyte Recirculation and Leukocyte Emigration
Springer, T. A. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004143 · Cited by 1,496
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,263 · cited 3×
“However, pro-metastatic effects of CXCL12 also may be regulated through CXCR4 on vascular endothelium [23], which upregulates and activates adhesion molecules to promote stable interactions with circulating cells [24], and/or CXCR7 [25], a newly identified second receptor for CXCL12 [26].”
BackgroundThe Structure and Function of the Endothelial Glycocalyx Layer
Weinbaum, S., Tarbell, J. M., & Damiano, E. R. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.151959 · Cited by 1,198
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment
Sipkins, D. A., Wei, X., Wu, J. W., Runnels, J. M., Côté, D., Means, T. K., Luster, A. D., Scadden, D. T., & Lin, C. P. (2005) · Nature · doi:10.1038/nature03703 · Cited by 878 · cited 1×
“The microfluidic vasculature reproduces preferential adhesion of circulating cancer cells to endothelia in organs and tissues with high levels of CXCL12 in vivo [31].”
BackgroundLong-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
Cailleau, R., Olivé, M., & Cruciger, Q. V. J. (1978) · In Vitro · doi:10.1007/bf02616120 · Cited by 679
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1529::aid-cncr2>3.3.co;2-# · Cited by 609
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1529::aid-cncr2>3.0.co;2-f · Cited by 581
Biomechanical activation of vascular endothelium as a determinant of its functional phenotype
García-Cardeña, G., Comander, J., Anderson, K. R., Blackman, B. R., & Gimbrone, M. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071052598 · Cited by 523 · cited 2×
“These static assays do not accurately model intravascular events in metastasis because blood flow alters gene expression [13,14], mechanical properties of cells [15,16], and cell adhesion [17,18].”
BackgroundHuh, D., Fujioka, H., Tung, Y.-C., Futai, N., Paine, R., Grotberg, J. B., & Takayama, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610868104 · Cited by 492 · cited 2×
“The microfluidic device (Figure 1A) consisted of two channel layers of 12:1 base to curing agent poly(dimethylsiloxane) (PDMS, Sylgard 184, Dow Corning) that sandwiched a semi-porous, optically clear polyester membrane [41].”
MethodSelf-citationPhillips, R. J., Burdick, M. D., Lutz, M., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-071oc · Cited by 455 · cited 2×
“CXCL12-mediated tropism of malignant breast [21], lung [11], and other cancer cells for characteristic sites of metastatic disease has been attributed predominantly to signaling through receptor CXCR4 on tumor cells [22].”
BackgroundChemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
Hatse, S., Princen, K., Bridger, G., De Clercq, E., & Schols, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03143-5 · Cited by 448 · cited 1×
“inhibitor of CXCL12 binding to CXCR4 but not CXCR7 [30] To eliminate confounding effects from cancer cell signaling we focused on 231-control breast cancer cells, which do not express CXCR4 or”
BackgroundKryczek, I., Lange, A., Mottram, P., Alvarez, X., Cheng, P., Hogan, M., Moons, L., Wei, S., Zou, L., Machelon, V., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.465.65.2 · Cited by 421 · cited 1×
“, which upregulates and activates adhesion molecules to promote stable interactions with circulating cells”
BackgroundCritical determinants of metastasis
Fidler, I. J. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0416 · Cited by 413
Chemokine Receptors in Human Endothelial Cells
Gupta, S. K., Lysko, P. G., Pillarisetti, K., Ohlstein, E., & Stadel, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4282 · Cited by 407 · cited 1×
“However, pro-metastatic effects of CXCL12 also may be regulated through CXCR4 on vascular endothelium [23], which upregulates and activates adhesion molecules to promote stable interactions with circulating cells [24], and/or CXCR7 [25], a newly identified second receptor for CXCL12 [26].”
BackgroundShear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines
Cinamon, G., Shinder, V., & Alon, R. (2001) · Nature Immunology · doi:10.1038/88710 · Cited by 402
Murakami, T., Maki, W. C., Cardones, A. R., Fang, H., Tun-Kyi, A., Nestle, F. O., & Hwang, S. T. (2002) · PubMed · Cited by 396
Ulbrich, H., Eriksson, E. E., & Lindbom, L. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.10.004 · Cited by 354 · cited 15×
“We region selectively treated this endothelium with various combinations of CXCL12, TNF-a and AMD3100, a specific inhibitor of CXCL12 binding to CXCR4 but not CXCR7 [30] To eliminate confounding effects from cancer cell signaling we focused on 231-control breast cancer cells, which do not express CXCR4 or CXCR7, bind…”
BackgroundInfluentialChemokines and leukocyte traffic
Sallusto, F., & Baggiolini, M. (2008) · Nature Immunology · doi:10.1038/ni.f.214 · Cited by 325
Grabovsky, V., Feigelson, S., Chen, C., Bleijs, D. A., Peled, A., Cinamon, G., Baleux, F., Arenzana-Seisdedos, F., Lapidot, T., van Kooyk, Y., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.495 · Cited by 324 · cited 1×
“. These effects of CXCR4 and CXCR7 on circulating cancer cells were observed in the absence of chemokine ligand, suggesting that basal, ligand-independent activation of these seven-transmembrane receptors is sufficient to increase adhesion to endothelium. CXCR4 is known to promote cell adhesion by stimulating binding…”
BackgroundTwo-photon imaging of capillary blood flow in olfactory bulb glomeruli
Chaigneau, E., Oheim, M., Audinat, E., & Charpak, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2133652100 · Cited by 304 · cited 1×
“reported in the microcirculation of potential sites of breast cancer metastasis”
BackgroundFunctions of CXCL12 and CXCR4 in breast cancer
Luker, K. E., & Luker, G. D. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.06.021 · Cited by 288 · cited 1×
“CXCL12-mediated tropism of malignant breast [21], lung [11], and other cancer cells for characteristic sites of metastatic disease has been attributed predominantly to signaling through receptor CXCR4 on tumor cells [22].”
BackgroundSelf-citationDNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress
CHEN, B. P. C., LI, Y.-S., ZHAO, Y., CHEN, K.-D., LI, S., LAO, J., YUAN, S., SHYY, J. Y.-J., & CHIEN, S. (2001) · Physiological Genomics · doi:10.1152/physiolgenomics.2001.7.1.55 · Cited by 278 · cited 2×
“These static assays do not accurately model intravascular events in metastasis because blood flow alters gene expression [13,14], mechanical properties of cells [15,16], and cell adhesion [17,18].”
BackgroundMazzinghi, B., Ronconi, E., Lazzeri, E., Sagrinati, C., Ballerini, L., Angelotti, M. L., Parente, E., Mancina, R., Netti, G. S., Becherucci, F., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071903 · Cited by 264 · cited 2×
“However, pro-metastatic effects of CXCL12 also may be regulated through CXCR4 on vascular endothelium [23], which upregulates and activates adhesion molecules to promote stable interactions with circulating cells [24], and/or CXCR7 [25], a newly identified second receptor for CXCL12 [26].”
BackgroundThe pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis
Wang, J., Loberg, R., & Taichman, R. S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9019-x · Cited by 256 · cited 1×
“Furthermore, all cells in a culture well are exposed to the same biochemical milieu, unlike physiologic conditions where gradients of signaling molecules in different anatomic locations typically are presented to the basal surface of endothelial cells [19,20].”
BackgroundBEUTLER, B., & CERAMI, A. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-1-57 · Cited by 251 · cited 1×
“Since TNF-a is produced mostly by macrophages located basal or extravascular to the endothelium [35,36], our system properly Figure 2.”
BackgroundComputer-Controlled Microcirculatory Support System for Endothelial Cell Culture and Shearing
Song, J. W., Gu, W., Futai, N., Warner, K. A., Nor, J. E., & Takayama, S. (2005) · Analytical Chemistry · doi:10.1021/ac050131o · Cited by 249 · cited 1×
“Human dermal microvascular cells (HDMECs, Lonza) passage numbers 6–8 were cultured in EBM-2+5% FBS+SingleQuot® kit (supplements such as VEGF, bFGF, etc) or EGM-2 MV (Lonza) as described previously”
MethodSelf-citationHeo, Y. S., Cabrera, L. M., Song, J. W., Futai, N., Tung, Y.-C., Smith, G. D., & Takayama, S. (2007) · Analytical Chemistry · doi:10.1021/ac061990v · Cited by 245 · cited 1×
“We note that the presence of the bottom channels (Figure 1E), which have relatively large volumes compared to the top channel, helps guard against nutrient depletion and evaporation prone to occur in PDMS-based microchannels [45].”
BackgroundSelf-citationChristopher, M. J., Liu, F., Hilton, M. J., Long, F., & Link, D. C. (2009) · Blood · doi:10.1182/blood-2008-10-184754 · Cited by 234 · cited 1×
“Furthermore, all cells in a culture well are exposed to the same biochemical milieu, unlike physiologic conditions where gradients of signaling molecules in different anatomic locations typically are presented to the basal surface of endothelial cells [19,20].”
BackgroundDesjardins, C., & Duling, B. R. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.258.3.h647 · Cited by 221
Leakage-Free Bonding of Porous Membranes into Layered Microfluidic Array Systems
Chueh, B.-H., Huh, D., Kyrtsos, C. R., Houssin, T., Futai, N., & Takayama, S. (2007) · Analytical Chemistry · doi:10.1021/ac062118p · Cited by 207 · cited 1×
“The layers were sealed together using a very thin (,10 mm) and uniform PDMS/toluene glue that provided robust, leakage-free sealing [42].”
MethodSelf-citationChemokines: novel targets for breast cancer metastasis
Ali, S., & Lazennec, G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9073-z · Cited by 180
Imaging 26S proteasome activity and inhibition in living mice
Luker, G. D., Pica, C. M., Song, J., Luker, K. E., & Piwnica-Worms, D. (2003) · Nature Medicine · doi:10.1038/nm894 · Cited by 174
Self-citationMicrofluidic System for Studying the Interaction of Nanoparticles and Microparticles with Cells
Farokhzad, O. C., Khademhosseini, A., Jon, S., Hermmann, A., Cheng, J., Chin, C., Kiselyuk, A., Teply, B., Eng, G., & Langer, R. (2005) · Analytical Chemistry · doi:10.1021/ac050312q · Cited by 174 · cited 1×
“The shear stress levels on the cells within the channels were modeled with the following equation [50,51]:”
MethodHastings, N. E., Simmers, M. B., McDonald, O. G., Wamhoff, B. R., & Blackman, B. R. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00385.2007 · Cited by 173 · cited 1×
“based systems that integrate Transwell inserts [37,38] but our”
BackgroundGaver, D. P., & Kute, S. M. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77562-9 · Cited by 171
Cardones, A. R., Murakami, T., & Hwang, S. T. (2003) · PubMed · Cited by 170
Chiu, J.-J., Chen, L.-J., Lee, P.-L., Lee, C.-I., Lo, L.-W., Usami, S., & Chien, S. (2003) · Blood · doi:10.1182/blood-2002-08-2560 · Cited by 167 · cited 1×
“based systems that integrate Transwell inserts [37,38] but our”
BackgroundGrober, J. S., Bowen, B. L., Ebling, H., Athey, B. D., Thompson, C. B., Fox, D. A., & Stoolman, L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116500 · Cited by 144
J�rneskog, G., Brismar, K., & Fagrell, B. (1995) · Diabetologia · doi:10.1007/bf00410286 · Cited by 141
CXCR2- and E-Selectin–induced Neutrophil Arrest during Inflammation In Vivo
Smith, M. L., Olson, T. S., & Ley, K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040424 · Cited by 138
Biomechanics of cell interactions in shear fields
Κωνσταντόπουλος, Κ., Kukreti, S., & McIntire, L. V. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00024-6 · Cited by 118
Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells.
Luker, K. E., Pica, C. M., Schreiber, R. D., & Piwnica-Worms, D. R. (2001) · PubMed · Cited by 89
Self-citationKanda, S., Mochizuki, Y., & Kanetake, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204771200 · Cited by 64
Schrage, A., Wechsung, K., Neumann, K., Schumann, M., Schulzke, J., Engelhardt, B., Zeitz, M., Hamann, A., & Klugewitz, K. (2008) · Hepatology · doi:10.1002/hep.22443 · Cited by 63 · cited 1×
“This capability provides proper modeling of the directionality of chemokine stimulation (basal originating instead of apical) at the vasculature of target sites for metastasis; a directionality previously shown to differentially regulate endothelial function [27].”
BackgroundMorzycki, W., Sadowska, J., & Issekutz, A. C. (1990) · Immunology Letters · doi:10.1016/0165-2478(90)90204-4 · Cited by 50
Murine alveolar macrophages limit replication of vaccinia virus
Rivera, R., Hutchens, M. A., Luker, K. E., Sonstein, J., Curtis, J. L., & Luker, G. D. (2007) · Virology · doi:10.1016/j.virol.2007.01.033 · Cited by 42 · cited 4×
“Chemokine receptor expression in the 231-CXCR4, PLoS ONE | www.plosone.org 7 June 2009 | Volume 4 | Issue 6 | e5756 231-CXCR7 cells, and 231-control cells was verified by flow cytometry (Figure 3A) as we have described previously, using mouse monoclonal antibodies to CXCR4 (12G5-PE, R&D Systems) or CXCR7 (11G8-APC, gi…”
MethodInfluentialSelf-citationMicromechanics of tumor cell adhesion and migration under dynamic flow conditions
Cheng, D. (2005) · Frontiers in bioscience · doi:10.2741/1535 · Cited by 30 · cited 1×
“These static assays do not accurately model intravascular events in metastasis because blood flow alters gene expression [13,14], mechanical properties of cells [15,16], and cell adhesion [17,18].”
BackgroundShear stress modulates tumour cell adhesion to the endothelium
Gomes, N., Bérard, M., Vassy, J., Peyri, N., Legrand, C., & Fauvel-Lafève, F. (2003) · Biorheology · doi:10.1177/0006355x2003040001003007 · Cited by 21 · cited 1×
“These static assays do not accurately model intravascular events in metastasis because blood flow alters gene expression [13,14], mechanical properties of cells [15,16], and cell adhesion [17,18].”
BackgroundChristopher, M. J., Hilton, M. J., Long, F., & Link, D. C. (2007) · Blood · doi:10.1182/blood.v110.11.220.220 · Cited by 4
Cited by
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
From 3D cell culture to organs-on-chips
Huh, D., Hamilton, G. A., & Ingber, D. E. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.005 · Cited by 1,834
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
A Review of Cell Adhesion Studies for Biomedical and Biological Applications
Khalili, A., & Ahmad, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818149 · Cited by 951
“[101] have developed a cancer cell metastasis model using microfluidic technology.”
MethodA Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice
Huh, D., Leslie, D. C., Matthews, B. D., Fraser, J. P., Jurek, S., Hamilton, G. A., Thorneloe, K. S., McAlexander, M. A., & Ingber, D. E. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004249 · Cited by 993
Metadata
- Authors
- Song, J. W., Cavnar, S. P., Walker, A. C., Luker, K. E., Gupta, M., Tung, Y.-C., Luker, G. D., & Takayama, S.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Luker, Gary D.
- Takayama, Shuichi
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-06-01
- Volume
- 4
- Issue
- 6
- Pages
- e5756
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2684591
- OpenAlex
- W2057771278
- Semantic Scholar
- 96d4b18c43a7bf97b9c928e4698b2ce061f1fb20
- Cited by
- 317
- References
- 56
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 11 · 2023: 11 · 2022: 12 · 2021: 15 · 2020: 23 · 2019: 25 · 2018: 24 · 2017: 33 · 2016: 18 · 2015: 28 · 2014: 23 · 2013: 30 · 2012: 23
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Susan G. Komen for the Cure
- Deutscher Akademischer Austauschdienst
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL-084370, R01HL084370)
- National Cancer Institute (R01CA136829, R01CA136553, P50CA093990)
- Army Research Office
- Army Research Laboratory
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- metastatic breast cancer, circulating tumor cells, microvascular endothelium, CXCL12, CXCR4, CXCR7, chemokine signaling, metastasis prevention
- MeSH terms
- Breast Neoplasms, Cell Adhesion, Cells, Cultured, Humans, Luciferases, Neoplasm Metastasis, Stress, Mechanical, Signal Transduction, Receptors, CXCR4, Reverse Transcriptase Polymerase Chain Reaction, Microfluidics, Cell Line, Tumor, Microfluidic Analytical Techniques, Chemokine CXCL12, Receptors, CXCR
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.